Views 259
Citations 0
Comment & Response
September 9, 2013

Patient Preferences for Deactivation of Implantable Cardioverter-Defibrillators

Author Affiliations
  • 1Department of Cardiology, Heart of England NHS Foundation Trust, Birmingham, England
  • 2Centre for the Study of Choice, University of Technology, Sydney, New South Wales, Australia
  • 3Faculty of Nursing, University of Alberta, Edmonton Alberta, Canada

Copyright 2013 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA Intern Med. 2013;173(16):1556-1557. doi:10.1001/jamainternmed.2013.8141

To the Editor The Research Letter on patient preferences for deactivation of implantable cardioverter-defibrillators (ICDs) provides useful data that may help avoid some device-related dilemmas increasingly encountered in clinical practice.1 Patients often intuitively accept the evidence-based offer of ICD therapy to avoid the specter of sudden death without fully appreciating the consequences of that decision.

First Page Preview View Large
First page PDF preview
First page PDF preview